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Abstract
Background: Diabetes is characterized by progressive failure of insulin producing beta cells. It is
well known that both saturated fatty acids and various products of immune cells can contribute to
the reduction of beta cell viability and functionality during diabetes pathogenesis. However, their
joint action on beta cells has not been investigated, so far. Therefore, we explored the possibility
that leukocytes and saturated fatty acids cooperate in beta cell destruction.
Results: Rat pancreatic islets or insulinoma cells (RIN) were co-cultivated with concanavalin A
(ConA)-stimulated rat lymph node cells (LNC), or they were treated with cell-free supernatants
(Sn) obtained from ConA-stimulated spleen cells or from activated CD3+ cells, in the absence or
presence of palmitic acid (PA). ConA-stimulated LNC or Sn and PA cooperated in inducing
caspase-3-dependent RIN cell apoptosis. The observed effect of PA and Sn on RIN cell viability was
mediated by p38 mitogen-activated protein kinase (MAPK)-signaling and was achieved through
auto-destructive nitric oxide (NO) production. The cooperative effect of Sn was mimicked with
the combination of interleukin-1β, interleukin-2, interleukin-6, interleukin-17, interferon-γ and
tumor necrosis factor-α.
Conclusion: These results imply that stimulated T cells produce cytokines that cooperate with
saturated free fatty acids in beta cell destruction during diabetes pathogenesis.
Background
Diabetes mellitus is a common name for a group of met-
abolic diseases characterized by hyperglycemia resulting
from defects in insulin secretion and/or action. Hypergly-
cemia and other related metabolic disturbances can lead
to serious damage to various systems of the body, espe-
cially nerves and blood vessels. Statistical data show that
the excess global mortality attributable to diabetes in the
year 2000 was 5.2% of all deaths [1], while its prevalence
for all age-groups worldwide was expected to increase
from 2.8% in 2000 to 4.4% in 2030 [2]. The most fre-
quent forms of diabetes mellitus are type 2 diabetes (T2D)
and type 1 diabetes (T1D).
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T2D is classically considered to be a metabolic disease
characterized by insulin resistance and additional disor-
ders, such as pancreatic beta cell dysfunction and decrease
in beta cell mass, which intensively contribute to the dis-
ease course [3,4]. One major reason for insulin resistance
in T2D is obesity [4,5], which is associated with high glu-
cose and free fatty acid levels circulating throughout the
body affecting various cell types including pancreatic beta
cells [6]. It is well known that hyperlipidemia contributes
to T2D pathogenesis [4,5,7], and that high concentrations
of saturated fatty acids, including palmitic acid (PA), lead
to impairment of insulin action and beta-cell dysfunction
[6,8,9]. Increased adiposity enhances adipose tissue secre-
tion of cytokines, such as TNF-α, IL-1β and IL-6 which are
cytotoxic to beta cells, as well as production of adipok-
ines, including leptin, resistin, and adiponectin, which
have a cytoprotective role in cytokine and free fatty acid-
induced beta cell destruction [10-12]. Obesity and insulin
resistance have been frequently associated with a state of
low-grade inflammation and therefore it is assumed that
inflammation contributes in a major way to the develop-
ment of T2D [4,13,14]. An accumulating set of data sup-
porting this assumption includes findings of
inflammation-related changes, such as amyloid deposits
and fibrosis, increased beta cell death and the presence of
leukocyte infiltrates in the pancreata of T2D patients and
animals [4,15,16]. Additionally, it is becoming increas-
ingly clear that obesity is also an important predisposing
factor for T1D [4,5], a disease with proposed autoimmune
etiopathology, in which immune cells infiltrate the endo-
crine pancreas and cause beta cell destruction [17]. The
means by which macrophages and T cells exert their cyto-
toxic actions upon beta cells are rather well established
and comprise various soluble mediators, such as oxygen
free radicals, nitric oxide (NO) and cytokines, including
IL-1β, IL-6, IFN-γ and TNF-α, but the primal target of the
autoimmune attack has not yet been defined [17]. It has
been suggested that physiological beta cell turnover may
expose specific tissue antigens that are carried to the drain-
ing lymph nodes by infiltrating macrophages [17]. Impor-
tantly, this initial turnover may be a consequence of
obesity, i.e. hyperlipidemia or the excess production of
cytokines in adipose tissues [4].
Thus, in the present paper we investigated the interaction
between one of the most common free fatty acid – PA and
soluble immune cell products, as they have individually
been shown to be deleterious for beta cells [8,11,18], but
their joint effect on beta cells has not been investigated so
far. Here, we demonstrate that PA and soluble products of
T cells cooperate in beta cell destruction in vitro. We show
that they trigger caspase-3-mediated, NO-dependent
apoptosis in rat insulinoma cells through activation of
p38 mitogen-activated protein-kinase (MAPK).
Methods
Reagents, cells and cell cultures
All reagents were from Sigma (St Louis, MO, USA) and all
dishes for culturing cells from Sarstedt (Numbrecht, Ger-
many), unless stated differently. To make the stock solu-
tion for further dilution in RPMI 1640, palmitic acid (PA)
was mixed overnight at 37°C in Krebs Ringer HEPES
buffer containing 20% BSA (fraction V, Roche, Basel, Swit-
zerland). The following recombinant cytokines were used
in the experiments: rat IFN-γ (R&D Systems, MI, USA, 10
ng/ml), mouse IL-17 (R&D Systems 50 ng/ml), mouse IL-
1β (10 ng/ml), rat TNF-α (10 ng/ml), human IL-2 (100
ng/ml), rat IL-6 (R&D Systems, 10 ng/ml). SB202190 was
used as a selective inhibitor of p38 MAPK activation and
was applied to cell cultures at least 30 minutes prior to
additional treatments. Hemoglobin (Hb, 20 mg/ml) was
used as the NO quencher, and was applied to cultures at
least 1 hour before additional treatments. Rat insulinoma
cells RINm5F (RIN) were grown under standard condi-
tions (37°C, 5% CO2) in RPMI 1640 medium supple-
mented with 5% fetal calf serum (FCS, PAA Chemicals,
Pasching, Austria), L-glutamine, 2-mercaptoethanol and
antibiotics (culture medium) in tissue culture flasks until
reaching approximately 80% confluence. Then, they were
detached with trypsin solution (0.25%) and ethylenedi-
aminetetraacetic acid (EDTA, 0.02%) in PBS. Cells were
washed and seeded into 96-well flat-bottom plates (1 ×
104/well) for the MTT test, cell-based ELISA and Griess
reaction, into 24-well plates (1 × 105/well) for co-cultiva-
tions, into 6-well plates (2.5 × 105/well) for cytofluori-
metric analysis, or tissue culture flasks (25 cm3, 1 × 106)
for western blot, ca. 16 hours before treatment. Subse-
quently, fresh culture medium with appropriate reagents
and/or cells was added to RIN cell cultures. Pancreatic
islets were isolated from male Dark Agouti (DA) rats using
the collagenase digestion method. The pancreata were
minced and subsequently incubated with collagenase
type V solution (1 mg/ml) in PBS at 37°C for 10 min with
vigorous shaking. After incubation, HBSS was added to
stop the digestion. The islets were handpicked and seeded
for the experiments into 96-well flat-bottom plates (4 ×
101/well) in culture medium (10% FCS). The islets were
used in experiments after an overnight rest. Lymph node
cells (LNC) were isolated from cervical lymph nodes from
DA rats and spleen cells from spleens of Albino Oxford
(AO) rats, DA rats, CBA mice, Balb/C mice and C57BL/6
mice. For the purification of T cells from LNC of DA rats,
anti-rat CD3-biotin conjugated antibody (BD Bio-
sciences), MACS streptavidin microbeads and MACS sep-
aration columns were used according to the instructions
of the manufacturer (Miltenyi Biotec, Aubum, CA). The
obtained cells were more than 98% positive for CD4 or
CD8 as deduced by cytofluorometry (FACS Calibur, BD
Biosciences), and were stimulated with plate bound anti-
CD3 (1 μg/ml) and anti CD28 (1 μg/ml) antibodies (eBi-BMC Immunology 2009, 10:29 http://www.biomedcentral.com/1471-2172/10/29
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oscience, San Diego, CA). The population of CD3- cells,
obtained by the same procedure as cells not bound to
CD3-biotin conjugated antibody were more than 98%
negative for CD3 (as deduced by cytofluorimetry) and
were stimulated with LPS (1 μg/ml, Sigma). Cell free
supernatants of CD3+ and CD3- cultures were collected
after 48 hours of cultivation. RIN cells and LNC (1 × 106/
well) were co-cultivated in the absence or presence of tis-
sue culture inserts (Nunc, Denmark). Spleen cell cultures
(5 × 106/ml) were stimulated with concanavalin A (ConA,
2.5 μg/ml) for 48 hours and subsequently cell-free super-
natants (Sn) were collected. Except in experiments where
10% Sn was combined with 32 μM PA, 40% Sn was
employed. α-Methyl-D-mannoside (10 mg/ml) was used
to neutralize the biological activity of ConA. The animals
were obtained from the breeding facility of the Institute
for Biological Research "Siniša Stanković" and were kept
under standardized conditions. All experiments were con-
ducted in accordance with local and international legisla-
tions regarding the wellbeing of laboratory animals.
Cell viability assay
In order to asses the viability of RIN cells, pancreatic islets
or LNC we used the mitochondrial-dependent reduction
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium
bromide (MTT) to formazan. At the end of appropriate
treatments, cell culture supernatants were removed from
the plates and MTT solution (1 mg/ml) was applied. Alter-
natively, pancreatic islets were collected in tubes, spun
down, supernatants removed and the cell pellet dissolved
in the MTT solution. Finally, in co-cultivation experi-
ments, LNC were removed from cell cultures, spun down,
supernatants removed and the residue dissolved in MTT
solution. MTT solution was also added to the RIN cells
remaining in the plates. Incubation with MTT lasted for
30 minutes at 37°C. Dimethyl sulfoxide (DMSO) was
added to the pellet of pancreatic islets, to LNC and to
plated RIN cells to dissolve the formazan crystals. The
absorbance was measured at 570 nm, with a correction at
690 nm, using an automated microplate reader (LKB
5060-006, LKB, Vienna, Austria).
Measurement of NO generation
Cytofluorimetric assay was used for direct measurement
of NO release with 4-amino-5-methylamino-2',7'-difluor-
ofluorescein (DAF-FM, 1 μM), which was added to cul-
tures 1 hour prior to the end of the treatment period. After
washing in PBS, the cells were detached, resuspended in
PBS and analyzed (excitation at 488 nm, emission at 510
nm) on a FACS Calibur flow cytometer (BD Biosciences).
Apoptosis detection and caspase-3 assay
Apoptotic cells were detected using an annexinV-FITC/
EtD-III staining kit (Biotium, Hayward, CA), according to
the manufacturer's protocol. Briefly, after treatment, RIN
cells were detached, resuspended in Annexin Binding
Buffer containing AnnexinV and EtDIII, and incubated in
the dark at room temperature for 15 minutes. Subse-
quently, samples were diluted with four volumes of
Annexin Binding Buffer and analysed with FACS Calibur
flow cytometer (BD Biosciences) using CellQuest Pro soft-
ware (BD Biosciences). The activity of caspase-3 was deter-
mined in cultures using the Caspase-3 DEVD-R110
Fluorimetric and Colorimetric Assay Kit (Biotium, CA),
according to the manufacturer's protocol. The ability of
cell lysates to cleave the specific caspase-3 substrate was
quantified fluorometrically using an excitation wave-
length of 485 nm and an emission wavelength of 535 nm
with a microplate reader (Chameleon, Hidex, Turku, Fin-
land). The results are expressed as amount of substrate
conversion (μM), deduced from a standard curve gener-
ated from known concentrations of the dye R110.
Western blot
Whole-cell lysates were prepared in a solution containing
62.5 mM Tris-HCl (pH 6.8, 2% w/v sodium dodecyl sul-
fate (SDS), 10% glycerol, 50 mM dithiothreitol (DTT),
0.01% w/v bromophenol blue, 1 mM phenylmethyl-
sulphonyl fluoride (PMSF), 1 μg/ml aprotinin, 2 mM
EDTA and were electrophoresed on a 12% SDS-polyacry-
lamide gel. The samples were electro-transferred to poly-
vinylidene difluoride membranes at 5 mA/cm2, using
semi-dry blotting system (Fastblot B43, Biorad, Munich,
Germany). The blots were blocked with 5% w/v nonfat
dry milk in PBS with 0.1% Tween-20 and probed with
specific antibodies to p38 and phosphorylated-p38 at
1:1000 dilution (both from Cell Signaling Technology,
Boston, MA), followed by incubation with secondary anti-
body at 1:10000 dilution (ECL donkey anti-rabbit horse-
radish peroxidase (HRP)-linked, GE Healthcare,
Buckinghamshire, England, UK). Detection was by chemi-
luminescence (ECL, GE Healthcare).
Cell-based ELISA
The expression of inducible nitric oxide synthase (iNOS)
was determined in triplicate by cell-based ELISA using
specific antibody (Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA), according to a previously described pro-
tocol [19]. Briefly, after adequate treatment RIN cells were
fixed in 4% paraformaldehyde (PFA), endogenous perox-
idase activity was quenched with hydrogen-peroxide and
the cells exposed to primary anti-iNOS antibody 1:200
dilution and secondary HRP-conjugated detection anti-
body (GE Healthcare) at 1:2000 dilution. The substrate
for HRP was 3,3',5,5'-tetra-methylbenzidine and the reac-
tion was stopped with 1 M HCl. The absorbance was
measured at 450 nm and the cells were stained with crys-
tal violet in order to correct for differences in cell num-
bers. The final results were obtained by division of the
absorbance at 450 nm after adding the stop solution andBMC Immunology 2009, 10:29 http://www.biomedcentral.com/1471-2172/10/29
Page 4 of 10
(page number not for citation purposes)
the absorbance at 570 nm after the additional crystal vio-
let staining (A450/A570).
Statistical Analysis
Data are presented as the mean +/- SD of values obtained
in independent experiments. Student's t-test was per-
formed for analysis of the differences between means
observed in the experiments.
Results
Cooperative effect of PA and activated immune cell 
products on rat pancreatic beta cell viability
We co-cultivated RIN cells and rat lymph node cells (LNC)
stimulated with ConA (2.5 μg/ml) in the absence or presence
of PA. In preliminary experiments the PA concentration of
125 μM had a significant, yet limited effect on RIN cell via-
bility (Fig 1A), so this dose was used in subsequent experi-
ments. After 20 hours of treatment, either PA or activated
LNC decreased RIN cell viability, but the effect was markedly
greater if RIN cells were co-cultivated with activated LNC in
the presence of PA (Fig 1B). Interestingly, if direct RIN-to-
LNC contact was prevented with tissue culture inserts, LNC
were unable to reduce RIN cell viability, but they still coop-
erated with PA in reducing RIN cell number (Fig 1C). This
result implied that soluble mediators produced by activated
immune cells cooperated with PA in inducing RIN cell death.
Such an assumption was confirmed, as supernatants
obtained from cultures of ConA-stimulated rat spleen cells
(Sn) also efficiently cooperated with PA in RIN cell destruc-
tion (Fig 1D). In order to eliminate the possibility that the
observed effects of Sn were mediated through direct action of
ConA upon RIN cells, Sn were treated with α-methyl-D-
mannoside (10 mg/ml) with the aim of blocking ConA
activity. The blocker did not interfere with the effect of Sn on
RIN cell viability (data not shown), thus excluding the possi-
bility of direct influence of ConA on RIN cells. Importantly,
Sn and PA also cooperated in the reduction of pancreatic
islets isolated from DA rats (Fig 1E), thus showing that the
observed effect was not specific for the transformed insuli-
noma cell line, but that it had relevance for beta cells in gen-
eral. Finally, with the purpose of investigating if lower
concentrations of PA and Sn also cooperate in reduction of
RIN cell viability, RIN cells were treated with 32 μM PA and
10% Sn. As presented in Fig 1F, individually PA and Sn had
just a limited inhibitory effect on RIN cells (12% and 11.4%,
respectively) but their joint effect was pronounced (44.6%).
This suggested that PA and Sn acted synergistically upon RIN
cells.
Sn and PA induce apoptosis of RIN cells
Our next aim was to explore if the observed decrease in
RIN cell viability was a consequence of apoptosis induc-
tion. Therefore, we analyzed AnnexinV-FITC and Et-DIII-
stained RIN cells cytofluorimetrically. While PA or Sn
obtained from DA rat spleen cells applied alone did not
induce significant apoptosis in RIN cells after 6 hours of
incubation, simultaneous application of PA and Sn
induced early apoptotic changes in more than 20% of the
cells (Fig 2A, C–F). Importantly, the pro-apoptotic effect
was also observed after just 2 hours of treatment (5–10%
of apoptotic cells), showing the rapidity of the influence.
These results once again indicated that PA and Sn cooper-
ate in a synergistic fashion. Moreover, increased activity of
the pro-apoptotic cleaving enzyme caspase-3 was found in
RIN cells subjected to the simultaneous treatment with PA
and Sn (Fig 2B). Thus, we could conclude that concurrent
application of PA and Sn decreased RIN cell viability
through caspase-3 dependent induction of apoptosis.
T cell cytokines cooperate with PA in the reduction of RIN 
cell viability
In order to investigate the nature of the component(s) of
Sn responsible for the observed cooperation with PA, Sn
made from C57BL/6 mouse spleen cells were tested for
efficiency in cooperation with PA. Importantly, Sn
obtained from C57BL/6 mouse spleen cells were as effi-
cient in the reduction of RIN cell viability as Sn obtained
from rat cells, both individually and in cooperation with
PA (Fig 3A). Moreover, similar efficiency was observed for
Sn obtained from CBA and Balb/C mice or AO rats (data
not shown). Thus, we could conclude that the soluble fac-
tor(s) involved in the cooperation with PA were not spe-
cies or strain-specific. Furthermore, we tested the
resistance of the soluble component(s) to heat by boiling
Sn for 10 min before use in the experiments. Exposure of
Sn to heat led to loss of the cooperative cytotoxic action of
Sn and PA (Fig 3B) indicating that heat-sensitive compo-
nents were responsible for the cooperation with PA in RIN
cell death induction. The possibility that cytokines present
in the Sn were involved in this cooperation was investi-
gated by treating RIN cells with the combination of IL-1β,
IFN-γ, TNF-α, IL-17, IL-2 and IL-6 in the absence or pres-
ence of PA. This combination of cytokines alone reduced
RIN cell number and also cooperated with PA in the
reduction of RIN cell viability (Fig 3C). The effect was sim-
ilar to that of Sn, so we could conclude that cytokines
might be responsible for the cooperative reduction of RIN
cell viability by Sn and PA. Finally, since Sn were products
of mixed populations of cells, including T cells, macro-
phages, B cells and other cell types, LNC were separated
into CD3+ cells (T cells) and CD3- cells (all the other cells),
by magnetic bead purification, and the obtained popula-
tions were used for production of Sn, in order to deter-
mine their relative contribution to the observed
cooperation. Importantly, Sn obtained from CD3+ cells
stimulated with anti-CD3 and anti-CD28 antibodies
cooperated with PA in the reduction of RIN cell viability
(Fig 3D). On the other hand, Sn obtained from CD3- cells
stimulated with LPS did not cooperate with PA in RIN cell
destruction. Hence, we could conclude that T cells were
producers of the cytokines responsible for the coopera-
tion with PA.BMC Immunology 2009, 10:29 http://www.biomedcentral.com/1471-2172/10/29
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PA and immune cells cooperate in pancreatic cell viability reduction Figure 1
PA and immune cells cooperate in pancreatic cell viability reduction. RIN cells were treated with various doses of 
PA (A), or they were cultivated alone (medium) or co-cultivated with LNC (B, C) in the absence (B) or presence (C) of tissue 
culture inserts, or cultivated in the presence of 40% Sn (D) or 10% Sn (F), in the absence or presence of 125 μM PA (B-D) or 
32 μM PA (F). Primary pancreatic islets were cultivated alone (medium) or in the presence of 40% Sn, in the absence or pres-
ence of 125 μM PA (E). MTT assay was performed after 20 hours of cultivation and the results are presented as the percentage 
of control absorbance values obtained for cultures grown in medium alone. Mean values +/- SD of values obtained in 8 (A), 14 
(B), 3 (C), 11 (D), 3 (E) and 6 (F) individual experiments are presented. *p < 0.05 represents a statistically significant difference 
between values obtained from RIN cell cultures treated with PA in the presence of LNC and any other culture of RIN cells or 
RIN cells treated with PA and Sn and any other culture of RIN cells.BMC Immunology 2009, 10:29 http://www.biomedcentral.com/1471-2172/10/29
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PA+Sn-induced RIN cell death is dependent on p38 MAPK 
activation
Our further goal was to determine if p38 MAPK-signaling is
involved in PA+Sn-induced apoptosis in RIN cells. As the
first step, SB202109, a selective p38 MAPK inhibitor, was
applied to RIN cultures treated with the combination of PA
and Sn, and this inhibitor was shown to prevent PA+Sn-trig-
gered apoptosis in RIN cells (Fig 4A). Accordingly, PA+Sn-
induced p38 MAPK activation was detected in RIN cells (Fig
4B), thus supporting the importance of p38 induction for
PA+Sn induced apoptosis in RIN cells. However, PA, but not
Sn, was able to activate p38 to the levels observed in cultures
treated with both PA and Sn. Thus, it seems that p38 activa-
tion is not enough for efficient initiation of RIN cell apopto-
sis, but that it is necessary for induction of the death of these
cells by coordinate action of PA and Sn.
Hemoglobin protects RIN cells from PA+Sn-induced 
apoptosis
We also explored if the effect of PA and Sn on RIN cell via-
bility was indirect, through induction of nitric oxide (NO)
production in these cells. Inducible nitric oxide synthase
(iNOS) expression measured by cell-based ELISA showed
that PA+Sn induced expression of this protein in RIN
cells, after 2 and 6 hours of incubation (Fig 5A). Addition-
ally, the treatment led to NO production in RIN cells,
while hemoglobin, a NO quencher, down-regulated the
levels of free NO (Fig 5B) and accordingly protected RIN
cells from apoptotic cell death induced by PA and Sn (Fig
5C). Importantly, the p38 signaling inhibitor – SB202109
that protected RIN cells from the cytotoxicity also inhib-
ited NO release in RIN cells (Fig 5D). Thus, these results
clearly suggest that NO produced in RIN cells in a p38-
dependent manner contributes to PA+Sn-induced RIN
cell apoptosis in a major way.
Discussion
In the present paper we show that cytokines produced by
T cells cooperate with a saturated free fatty acid in the
induction of beta cell apoptosis. The observed coopera-
tion is synergistic both at the level of the intensity and the
speed of the action. Importantly, the cooperative effect
Apoptotic cell death of RIN cells under the influence of PA and Sn Figure 2
Apoptotic cell death of RIN cells under the influence of PA and Sn. RIN cells were cultivated in the absence (medium) 
or presence of 125 μM PA and/or 40% Sn for 6 hours (A, C-F) or 4 hours (B). Subsequently, the cells were stained with AnnV/
EtD-III and cytofluorimetric acquisition and analysis were performed (A, C-F) or they were analyzed for caspase-3 activity (B). 
Mean values +/- SD of values obtained in 3 (A) and 4 (B) individual experiments with similar results are presented. *p < 0.05 
represents a statistically significant difference between values obtained from cultures of RIN cells treated with PA and Sn and 
any other culture of RIN cells. Plots of the cells stained with AnnV/EtD-III from a representative experiment are presented in 
the lower panel (C-F), where numbers in the lower right quadrant of the plots are the percentage of apoptotic cells and num-
bers in the upper right quadrant are the percentage of necrotic cells.BMC Immunology 2009, 10:29 http://www.biomedcentral.com/1471-2172/10/29
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was also observed if primary pancreatic islets were used as
the target population, thus excluding the possibility that
the cytotoxicity was specific for the transformed cell line.
There is an increasing number of reports indicating the
importance of saturated fatty acids or soluble products of
immune cells, including cytokines and NO in the reduc-
tion of beta cell mass during diabetes pathogenesis
[8,11,18]. Nevertheless this is the first report to our
knowledge, that describes cooperation between a satu-
rated fatty acid and soluble immune mediators in the
destruction of pancreatic beta cells. The fact that soluble
mediators cooperate with PA is clearly shown in the exper-
iments where RIN cells and LNC were separated with tis-
sue-culture inserts, and substantiated with the
corresponding results obtained with cell-free Sn. Moreo-
ver, similar efficiency of Sn from various strains of rats and
mice, clearly suggests that product(s) responsible for the
observed cooperation are not species- or strain-specific.
Furthermore, the inability of heat-treated Sn to cooperate
with PA in RIN cell destruction implies that the soluble
product(s) are heat-sensitive, i.e. proteins. The obvious
protein candidates are cytokines, as IL-1β, IL-6, IFN-γ and
TNF-α have been shown to be efficient in β-cell destruc-
tion [8,11,17,18]. Additionally, we previously reported
that IL-17 contributes to NO-dependent cytotoxicity of
beta cells [20]. Moreover, one of the major constituents of
Sn – IL-2 was found to cooperate with PA in the activation
Cooperation of mouse Sn, heated Sn, cytokines, CD3+Sn with PA in reduction of RIN cell viability Figure 3
Cooperation of mouse Sn, heated Sn, cytokines, CD3+Sn with PA in reduction of RIN cell viability. RIN cells 
were cultivated in the absence (medium) or presence of 125 μM PA and/or 40% C57Bl/6 mouse Sn (SnM – A), and/or 40% Sn 
or Sn boiled for 10 minutes (SnB-B), and/or 10 ng/ml IL-1β, 10 ng/ml IL-6, 10 ng/ml IFN-γ, 10 ng/ml TNF-α, 50 ng/ml IL-17 and 
100 ng/ml IL-2 (cytokines – C) and/or 40% Sn obtained from CD3+ LNC or CD3- LNC (SnCD3+, SnCD3- – D). MTT assay was 
performed after 20 hours of cultivation and the results are presented as the percentage of control absorbance values obtained 
in cultures grown in medium alone. Mean values +/- SD of values obtained in 11 (A), 7 (B), 5 (C) and 4 (D) individual experi-
ments with similar results are presented. *p < 0.05 represents a statistically significant difference between values obtained from 
cultures of RIN cells treated with PA and SnM (A) or PA and Sn (B) or PA and cytokines (C) or PA and SnCD3+ (D) and any 
other culture of RIN cells.BMC Immunology 2009, 10:29 http://www.biomedcentral.com/1471-2172/10/29
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of Jak-3 and STAT-5 in human lymphocytes [21]. There-
fore, we used the combination of IL-1β, IL-6, IFN-γ, TNF-
α, IL-17 and IL-2 and were able to mimic the effects of Sn
on RIN cells. Finally, the observed ability of Sn obtained
from pure CD3+, but not CD3- cells, to cooperate with PA
in reducing RIN cell viability indicates that T cells are the
major cell population responsible for the production of
the soluble product(s) which cooperate with PA in the
process. Importantly, the cytokines we used to mimic the
effect of Sn are either typical T-cell products (IL-2, IFN-γ,
IL-17) or they can be produced by various cells including
T cells (IL-6, IL-1β, TNF-α). This is in agreement with the
observed ability of pure CD3+ cell culture supernatants to
affect RIN cell viability. Also, if we take into account that
some cytokines (IL-6, IL-1β, TNF-α) can be produced by B
cells, macrophages and other CD3- cells, and that produc-
tion of all of the cytokines by T cells could be supported
by CD3- cells, it becomes clear why CD3+ cells produced a
"weaker" supernatant than lymph node cells. Moreover
the inability of CD3- cells to provide a supernatant effec-
tive against RIN cells, leaves us with T lymphocytes as the
prime suspects for the cooperation with fatty acids in the
destruction of beta cells in diabetes.
Furthermore, we can conclude that the major signaling
pathway responsible for the induction of apoptosis in RIN
cells under the coordinated influence of PA and Sn is the
p38 MAPK pathway. This conclusion is based on the p38-
activation observed under the influence of PA and Sn, as
well as on the complete protection of RIN cells from the
apoptosis induction by the specific p38 signaling inhibi-
tor. It is well known that p38 is involved in induction of
apoptosis [22], and more specifically in the induction of
apoptosis of beta cells, under the influence of both
cytokines [23,24] and PA [25]. In our hands PA, but not
Sn, was able to activate p38 in RIN cells. However,
although PA potently induced p38 in RIN cells, it did not
cause massive apoptosis. Importantly, with the same level
of p38 activation under the cooperative action of PA and
Sn, a substantial proportion of RIN cells underwent apop-
totic changes, while inhibition of the p38 signaling path-
way prevented the induction of apoptosis in RIN cells.
Thus, it seems that activation of p38 per se is not enough
for apoptosis induction in RIN cells, but at the same time
p38 activation is probably necessary for the observed
cooperative induction of apoptosis in these cells.
Finally, the major effector molecule responsible for RIN
cell apoptosis may be NO. Namely, the NO scavenger Hb
protects RIN cells from the deleterious effect of PA and Sn,
while the p38 signaling inhibitor, which inhibits PA+Sn-
imposed apoptosis of RIN cells, also prevents PA+Sn-
induced NO synthesis in these cells. The importance of
NO for induction of beta cell apoptosis by cytokines has
been repeatedly reported, while the role of NO in fatty
acid induced death of beta cells is still controversial. For
instance, it was shown that IL-1 or TNF-α induced cell
death in INS-1 cells and that IL-1, but not palmitate or
oleate potently induced iNOS gene expression and NO
generation in these cells [8]. There are, however, findings
indicating the ability of primary beta cells to produce NO
and express both constitutive and inducible isoforms of
NOS under the influence of PA [25-27]. In our experi-
ments, massive production of NO was observed in RIN
cells under the coordinated action of PA and Sn. The nov-
elty of our finding is that PA could contribute to NO
induction in the inflammatory milieu, represented in our
experiments by Sn. Generally, it is thought that NO-
The involvement of p38 MAPK signaling pathway in the induction of apoptosis of RIN cells under the influence of PA and Sn Figure 4
The involvement of p38 MAPK signaling pathway in the induction of apoptosis of RIN cells under the influence 
of PA and Sn. RIN cells were cultivated in the absence (medium) or presence of 125 μM PA and/or 40% Sn. For apoptosis 
detection, RIN cells were treated with PA and Sn in the absence or presence of an inhibitor of p38 MAPK signaling – SB202109 
(40 μM) for 6 hours, and subsequently stained with AnnV/EtD-III (A). Alternatively, RIN cells were treated with PA and/or Sn 
for 1 hour, then cell lysates were made before western blotting for p38 MAPK and phosphorylated p38 (p-p38) (B, C). Mean 
values +/- SD of values obtained in 5 (A) and 3 (B) individual experiments with similar results are presented, or a representa-
tive western blot (C). *p < 0.05 represents a statistically significant difference relative to the cultures grown in medium without 
additional treatment (A, B) and to the cultures treated with SB (A).BMC Immunology 2009, 10:29 http://www.biomedcentral.com/1471-2172/10/29
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dependent destruction of beta cells is characteristic of
T1D, where immune cells infiltrate pancreatic islets and
produce NO-inducing cytokines, while on the contrary
fatty acids do not provoke NO-dependent cell death in
T2D [28]. Here, we show that PA is able to cooperate with
Sn in inducing NO synthesis. Thus, it seems reasonable to
assume that free fatty acid levels could be very important
for the destruction of beta cells during ongoing inflamma-
tion in the pancreas. Such a reasoning favors hypotheses
that inflammation is important for the development of
T2D, as well as that obesity is a predisposing factor for
T1D [4,5].
Taken together, as it was shown that both NO and p-38
signaling contribute to apoptosis induction in RIN cells
under the influence of PA and Sn in a major way, it is
tempting to speculate that in our system the cooperative
effect of PA and Sn is dependent on activation of p38,
which in turn leads to generation of NO and destruction
of RIN cells. Once NO is generated, p38 might play an
important role in the predisposition of RIN cells to NO-
imposed apoptosis, as genetic down-regulation of p38α
was previously shown to lower the sensitivity of beta cells
to cell death induced by a NO donor [24]. Importantly,
besides its role in classical induction of apoptosis, p38
activity has been assigned a major role in endoplasmatic
reticulum (ER) stress-induced apoptosis [29]. Also, NO
produced in beta cells under the influence of cytokines
has been shown to contribute largely to the induction of
ER-stress in beta cells [30]. Thus, the possibility of the
involvement of the ER stress components in the observed
effect of PA and cytokines on beta cells should be investi-
gated in the future.
Conclusion
Our results imply that limited hyperlipidemia and inflam-
mation, when acting in concert, may carry out a powerful
attack upon pancreatic beta cells. The cooperative cyto-
toxic effect of palmitate and soluble T cell products
described herein has clear significance for understanding
the pathogenesis of diabetes, as it suggests that there
might be direct cooperation between factors of obesity
and inflammation in beta cell destruction. However, as
our data are from a simplified in vitro experimental sys-
PA and Sn induce RIN cell apoptosis through induction of nitric oxide production Figure 5
PA and Sn induce RIN cell apoptosis through induction of nitric oxide production. RIN cells were cultivated with-
out treatment (medium) or treated with Sn and/or PA and/or hemoglobin (Hb, 20 mg/ml) and/or SB202109 (40 μM). After 2 or 
6 hours RIN cells were fixed before cell-based ELISA for iNOS (A). Cells were stained with DAF-FM (B, D) and AnnV/EtD-III 
(C) after 6 hours of cultivation. Mean values +/- SD of values obtained in three individual experiments with similar results are 
presented (A, C). Alternatively, plots from a representative of at least three experiments with similar data are presented (B, 
D). *p < 0.05 represents a statistically significant difference relative to the cultures grown in medium without additional treat-
ment (A, C) and to the cultures treated with Hb (C).BMC Immunology 2009, 10:29 http://www.biomedcentral.com/1471-2172/10/29
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tem, it requires future in vivo/ex vivo studies to provide
insights about the feasibility of the observed cooperation
in living organisms.
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